Pathogenesis of atherosclerosis: A possible relation to infection

Atherosclerosis

Volumn 140, Issue SUPPL. 1, 1998, Pages

  Noll, Georg ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Atherosclerosis; Chlamydia pneumoniae; Endothelin; Endothelium; Infection; Inflammation; Nitric oxide; Oxidised LDL

Indexed keywords

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC INFLAMMATION; CONFERENCE PAPER; DISEASE ASSOCIATION; ENDOTHELIUM INJURY; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; RISK FACTOR; SEROEPIDEMIOLOGY;

ANIMALS; ARTERIOSCLEROSIS; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; PROGNOSIS; RISK ASSESSMENT;

EID: 0031788882     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00113-0     Document Type: Conference Paper

References (31)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
2. Crossman D. The future of the management of ischaemic heart disease. BMJ 1997;314:356-9.
3. Lüscher TF, Noll G. The pathogenesis of cardiovascular disease: role of the endothelium as a target and mediator. Atherosclerosis 1995;118:S81-90.
4. Lüscher TF, Noll G. Endothelium dysfunction in the coronary circulation. J Cardiovasc Pharmacol 1994;24:S16-26.
5. Noll G, Lüscher TF. Influence of lipoproteins on endothelial function. Thromb Res 1994;74:S45-54.
6. Lüscher TF, Tanner FC, Noll G. Lipids and endothelial function: effects of lipid-lowering and other therapeutic interventions. Curr Opin Lipidol 1996;7:234-40.
7. Lüscher TF, Wenzel RR, Noll G. Local regulation of the coronary circulation in health and disease: role of nitric oxide and endothelin. Eur Heart J 1995;16:51-8.
8. De Caterina R, Libby P, Peng HB, et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995;96(1):60-8.
9. Zeiher AM, Fisslthaler B, Schray-Utz B, et al. Nitric oxide modulates the expression of monocyte chemoattractant protein-1 in cultured human endothelial cells. Circ Res 1995;76(6):980-6.
10. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. New Engl J Med 1994;331(7):417-24.
11. Liuzzo G, Biasucci LM, Rebuzzi AG, et al. Plasma protein acute-phase response in unstable angina is not induced by ischemic injury. Circulation 1996;94(10):2373-80.
12. Biasucci LM, Vitelli A, Liuzzo G, et al. Elevated levels of interleukin-6 in unstable angina. Circulation 1996;94(5):874-7.
13. Linnanmaki E, Leinonen M, Mattila K, et al. Presence of Chlamydia pneumoniae-specific antibodies in circulating immune complexes in coronary heart disease. Circulation 1993;87:1130-4.
14. Melnick SL, Shahar E, Folsom AR, et al. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Am J Med 1993;95:499-504.
15. Thom DH, Grayston T, Siscovick DS, et al. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. J Am Med Assoc 1992;268:68-72.
16. Gupta S, Camm AJ. Chlamydia pneumoniae and coronary heart disease. Br Med J 1997;314:1778-9.
17. Syrjanen J. Central nervous system complications in patients with bacteremia. Scand J Infect Dis 1989;21(3):285-96.
18. Grau AJ, Buggle F, Heindl S, et al. Recent infection as a risk factor for cerebrovascular ischemia. Stroke 1995;26:373-9.
19. Nieminen MS, Mattila K, Valtonen V. Infection and inflammation as risk factors for myocardial infarction. Eur Heart J 1993;14:12-6.
20. Spodick DH, Flessas AP, Johnson MM. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol 1984;53:481-2.
21. Jousilahti P, Vartiainen E, Tuomilehto J, et al. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 1996;346:567-72.
22. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
23. Fabricant CG, Fabricant J, Litrenta MM, et al. Virus-induced atherosclerosis. J Exp Med 1978;148:335-40.
24. Saikku P, Mattila K, Nieminen MS, et al. Serological evidence of an association of a novel Chlamydia TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2(8618):983-6.
25. Mendall MA, Carrington D, Strachan D, et al. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect 1995;30:121-8.
26. Blasi F, Cosentini R, Racconelli R, et al. A possible association of Chlamydia pneumoniae infection and acute myocardial infarction in patients younger than 65 years of age. Chest 1997;112(2):309-12.
27. del Piano M, Sessa R, DiPietro M, et al. Chlamydia pneumoniae infection and atherosclerotic coronary disease: a new possible ethiopathogenic association. In: Stary A, editor. Proceedings of the Third Meeting of the European Society for Chlamydia Research, p 225.
28. Shor A, Kuo CC, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 1992;82:158-61.
29. Kuo CC, Shor A, Campbell LA, et al. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993;157:841-9.
30. Campbell LA, O'Brien ER, Cappuccio AL, et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 1995;172:585-8.
31. Kuo CC, Grayston JT, Campbell LA, et al. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years). Proc Natl Acad Sci USA 1995;92:6911-4.